Analyst Ratings for Moderna (MRNA) [Buys]
MRNA Rating Summary
MRNA Price Target Summary
- Highest: $246.00 (Piper Sandler)
- Lowest: $83.00 (SVB Leerink)
- Average: $162.46
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$162.46 (-25.8%)
* Over Last 12-Mos
Rating Score: 5 / 10
Percentile Rank: 50%
Avg. $ Target:
$162.46 (-25.8%)
* Over Last 12-Mos
Rating Score: 5 / 10
Percentile Rank: 50%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/13/2020 | Brookline Capital Markets » Updated 6/8/2021 |
Leah Rush Cann | New Coverage | Buy (N/A) |
224.00 (205.00) |
62.61 (218.85) |
249.54% | Details |
| 6/30/2020 | Argus » Updated 12/1/2020 |
John Eade | New Coverage | Buy (N/A) |
200.00 (88.00) |
62.08 (218.85) |
252.53% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
